GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Esperion Therapeutics Inc. (ESPR) [hlAlert]

Rating:
Buy ESPR
up 105.57 %

Esperion Therapeutics Inc. (ESPR) rated Buy with price target $115 by Needham

Posted on: Wednesday,  Aug 19, 2015  8:25 AM ET by Needham

Needham rated Buy Esperion Therapeutics Inc. (NASDAQ: ESPR) on 08/19/2015. Previously Needham rated Buy Esperion Therapeutics Inc. (NASDAQ: ESPR) on 10/27/2014.,
when the stock price was $25.30. Since then, Esperion Therapeutics Inc. has gained 105.57% as of 01/05/2016's recent price of $52.01.
If you would have followed the previous Needham's recommendation on ESPR, you would have gained 105.57% of your investment in 435 days.



Needham & Company, LLC focuses on emerging growth companies in technology, biotechnology and life sciences. The firm's research goal is to service the needs of growth-oriented institutional clients. Needham & Company has established itself as a premier specialty investment bank providing timely and valuable analysis on companies that are under-covered by the majority of Wall Street firms.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/19/2015 8:25 AM Buy
None
62.80 115.00
as of 8/27/2015
1 Week down  -11.45 %
1 Month down  -35.76 %
3 Months down  -51.72 %
1 YTD down  -17.18 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/10/2015 8:25 AM Buy
None
61.30 130.00
5/8/2015 8:25 AM Buy
None
103.40 130.00
10/27/2014 8:25 AM Buy
None
25.30 47.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy